Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECOVER-AUTONOMIC (Ivabradine): Randomized Trial of the Effect of Ivabradine Versus Placebo on Long COVID Symptoms

NCT06305806 is registered in ClinicalTrials.gov with Kanecia Obie Zimmerman as lead sponsor.

NCT NCT06305806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06305806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECOVER-AUTONOMIC (Ivabradine): Randomized Trial of the Effect of Ivabradine Versus Placebo on Long COVID Symptoms
Lead sponsor
Kanecia Obie Zimmerman
Phase
Phase 2
Overall status
Completed
Start date
March 11, 2024
Completion date
December 17, 2025
Enrollment
181 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, long covid-19, long covid19